Showing 8481-8490 of 8647 results for "".
- Nation’s Ophthalmologists Remind Congress of the Importance of Medical and Surgical Eye Carehttps://modernod.com/news/nations-ophthalmologists-remind-congress-of-the-importance-of-medical-and-surgical-eye-care/2480227/More than 400 eye physicians and surgeons from across the United States are in Washington DC to urge Congress to preserve every patients’ access to quality medical and surgical eye care. As part of its annual visit to Capitol Hill, the
- Bausch + Lomb Receives FDA 510(k) Clearance for Boston Scleral Lens Casehttps://modernod.com/news/bausch-lomb-receives-fda-510k-clearance-for-boston-scleral-lens-case/2480229/Bausch + Lomb announced that it has received 510(K) clearance from the FDA for the Boston scleral lens case, a storage case developed specifically for scleral lenses. The case is designed to hold lenses up to 23.5 millimeters in diameter and up to 10.0 millimeters in sagittal depth. The Boston sc
- Telemedicine Useful in Detecting Retinopathy of Prematurityhttps://modernod.com/news/telemedicine-useful-in-detecting-retinopathy-of-prematurity/2480230/Telemedicine has similar accuracy to ophthalmoscopy in detecting clinically significant retinopathy of prematurity (ROP), researchers say, according to a report in Reuters Health. “ROP is a leading cause of childhood blindness in the U.S. and throughout the world, yet it is often dif
- Optimo Medical Receives CE Mark for Optimeyes Surgical Planning Toolhttps://modernod.com/news/optimo-medical-receives-ce-mark-for-optimeyes-surgical-planning-tool/2480233/Switzerland-based Optimo Medical AG announced that it has received CE Mark for Optimeyes as a Class 2b medical device. The Optimeyes software predicts in a patient-specific way the influence of physical interventions in the cornea, allowing it to simulate and evaluate treatment results in
- Genetically Modified Cornea Safely and Effectively Prevents Rejection Post-Transplantationhttps://modernod.com/news/genetically-modified-cornea-safely-and-effectively-prevents-rejection-post-transplantation/2480247/Researchers engineered a donor cornea, introducing two genes intended to prevent new blood vessel formation following transplantation, and have shown this novel approach to be safe, well tolerated, and effective at reducing the risk of tissue rejection in a high-risk rabbit model, according to a
- New Data from the HORIZON Trial of the Hydrus Microstent Shows Lower IOP and Medication Usehttps://modernod.com/news/new-data-from-the-horizon-trial-of-the-hydrus-microstent-shows-lower-iop-and-medication-use/2480249/Ivantis announced that the HORIZON US cohort data will be presented at the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Washington DC on Saturday, April 14, 2018. The full global HORIZON pivotal
- SERI Lugano: ParaCel Riboflavin Selected by FDA for Epi-on Cross-Linking for Keratoconushttps://modernod.com/news/seri-lugano-paracel-riboflavin-selected-by-fda-for-epi-on-cross-linking-for-keratoconus/2480255/The Switzerland Eye Research Institute has announced that the breakthrough transepithelial riboflavin formulation known as ParaCel, and based on the research of its CEO and Founder Roberto Pinelli, MD, has been selected among many others by the FDA for an epithelium-on corneal collagen cross-link
- Veteran Business Development Executive Joins Lions Eye Institute as CMOhttps://modernod.com/news/veteran-business-development-executive-joins-lions-eye-institute-as-cmo/2480260/The Lions Eye Institute for Transplant & Research has announced the hiring of its first Chief Marketing Officer, Art Kurz, to strengthen the organization’s business development activities. Mr. Kurz, a former U.S. Air Force medic and graduate of Towson University, comes to Lions Eye Ins
- Johnson & Johnson Vision Introduces Contact Lens with Transitions Light Intelligent Technologyhttps://modernod.com/news/johnson-johnson-vision-announces-contact-lens-innovation-with-acuvue-oasys-with-transitions-light-intelligent-technology/2480264/Johnson & Johnson Vision has introduced the Acuvue Oasys with Transitions Light Intelligent Technology, a first-of-its-kind contact lens that provides wearers with vision correction and a dynamic photochromic filter that helps to continuously balance the amount of light entering the eye, acco
- Dallas Lighthouse for the Blind to Merge With Envisionhttps://modernod.com/news/dallas-lighthouse-for-the-blind-to-merge-with-envision/2480267/Envision announced that it has acquired the Dallas Lighthouse for the Blind. Operations will continue as normal in Dallas, and the Dallas Lighthouse for the Blind name will be retained. Financial terms of the deal were not disclosed. The merger will have positive benefits both in Te